
Sign up to save your podcasts
Or


An interview with Dr. Nancy E. Davidson from Fred Hutchinson Cancer Research Center and University of Washington on the guideline update which provides recommendations on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines
By American Society of Clinical Oncology (ASCO)4.6
4343 ratings
An interview with Dr. Nancy E. Davidson from Fred Hutchinson Cancer Research Center and University of Washington on the guideline update which provides recommendations on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines

135 Listeners

320 Listeners

496 Listeners

40 Listeners

17 Listeners

115 Listeners

57 Listeners

291 Listeners

3,331 Listeners

187 Listeners

22 Listeners

26,653 Listeners

189 Listeners

42 Listeners

3 Listeners